Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1859 (LINC01859) is a gene that produces a long non-coding RNA transcript not overlapping with annotated protein-coding genes[1][3][5][8]. As a member of the lincRNA family, LINC01859 does not encode a protein but may have regulatory functions in gene expression, chromatin remodeling, or cell biology—though these general roles are inferred from the broader lincRNA category and are not yet experimentally validated for this specific RNA[5][8]. There is currently no direct evidence linking LINC01859 to major diseases, clinical use, or therapeutic interventions; it is cataloged in genomic databases primarily as a transcript of unknown function. If detailed functional, disease, or therapeutic relevance emerges in future research, these entries may be updated.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1859 (LINC01859).